PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
18.48%
Revenue growth above 1.5x OBE's 0.18%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
32.96%
Gross profit growth above 1.5x OBE's 2.87%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-5.94%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-5.94%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-31.82%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-32.50%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-31.93%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
38.84%
OCF growth at 50-75% of OBE's 67.84%. Martin Whitman would question if the firm lags in monetizing sales effectively.
198.09%
Positive FCF growth while OBE is negative. John Neff would see a strong competitive edge in net cash generation.
2.64%
Positive 10Y revenue/share CAGR while OBE is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
-34.07%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-77.73%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
-11.21%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-55.45%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-52.11%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-90.29%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-96.56%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
357.84%
10Y equity/share CAGR above 1.5x OBE's 54.63%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
-1.47%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-28.54%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
101.92%
Stable or rising mid-term dividends while OBE is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
-49.90%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-5.19%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-50.00%
Inventory is declining while OBE stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.60%
Negative asset growth while OBE invests at 2.29%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.42%
We have a declining book value while OBE shows 0.02%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
1.88%
Debt growth far above OBE's 2.96%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-35.82%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.